SPRY4-AS1, A Novel Enhancer RNA, Is a Potential Novel Prognostic Biomarker and Therapeutic Target for Hepatocellular Carcinoma

A growing number of evidence have demonstrated the involvement of enhancer RNAs (eRNAs) in tumor progression. However, the possible functions of eRNAs in hepatocellular carcinoma (HCC) remain largely unclear. Our present research aimed to screen critical eRNAs and to further delve into the clinical...

Descripción completa

Detalles Bibliográficos
Autores principales: Ye, Mu, Wang, Sheng, Qie, Jing-bo, Sun, Pei-long
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8521147/
https://www.ncbi.nlm.nih.gov/pubmed/34671565
http://dx.doi.org/10.3389/fonc.2021.765484

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8521147/
https://www.ncbi.nlm.nih.gov/pubmed/34671565
http://dx.doi.org/10.3389/fonc.2021.765484

Ejemplares similares